1832 Asset Management’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.43M | Sell |
4,980
-292
| -6% | -$83.9K | ﹤0.01% | 527 |
|
|
2025
Q1 | $1.63M | Sell |
5,272
-186
| -3% | -$57.3K | ﹤0.01% | 489 |
|
|
2024
Q4 | $1.93M | Buy |
5,458
+211
| +4% | +$74.4K | ﹤0.01% | 486 |
|
|
2024
Q3 | $1.88M | Buy |
5,247
+343
| +7% | +$123K | ﹤0.01% | 533 |
|
|
2024
Q2 | $1.56M | Buy |
+4,904
| New | +$1.56M | ﹤0.01% | 530 |
|
|
2018
Q3 | – | Sell |
-30
| Closed | -$4K | – | 720 |
|
|
2018
Q2 | $4K | Hold |
30
| – | – | ﹤0.01% | 618 |
|
|
2018
Q1 | $3K | Sell |
30
-185
| -86% | -$18.5K | ﹤0.01% | 643 |
|
|
2017
Q4 | $32K | Sell |
215
-295
| -58% | -$43.9K | ﹤0.01% | 571 |
|
|
2017
Q3 | $60K | Buy |
510
+18
| +4% | +$2.12K | ﹤0.01% | 569 |
|
|
2017
Q2 | $64K | Buy |
492
+12
| +3% | +$1.56K | ﹤0.01% | 540 |
|
|
2017
Q1 | $65K | Sell |
480
-670
| -58% | -$90.7K | ﹤0.01% | 579 |
|
|
2016
Q4 | $166K | Buy |
+1,150
| New | +$166K | ﹤0.01% | 627 |
|